Long-term use of postmenopausal estrogen and progestin hormone therapies and the risk of endometrial cancer

These results support the hypotheses that continuous combined therapy does not increase (and may decrease) endometrial cancer risk and that long-term sequential therapy can lead to a modest increased risk. However, the collective results of all studies of these questions and their clinical implications remain unclear.